Estrella Immunopharma, Inc. announced that Effective as of the closing date of the Business Combination on September 29, 2023, the Company?s fiscal year end changed from December 31 to June 30. This change aligns the Company?s fiscal year and financial reporting periods with that of Estrella, the accounting acquirer in the Business Combination.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9468 USD | +7.59% | -4.56% | -14.70% |
1st Jan change | Capi. | |
---|---|---|
-14.70% | 34.44M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- ESLA Stock
- News Estrella Immunopharma, Inc.
- Estrella Immunopharma, Inc. Announces Changes to Fiscal Year End from December 31 to June 30